Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain
Brain cells that die after stroke release intracellular proteins into their environment. Akihiko Yoshimura and his colleagues demonstrate that peroxiredoxin proteins released from dying cells induce inflammatory cytokine expression and drive brain damage after stroke. Post-ischemic inflammation is a...
Gespeichert in:
Veröffentlicht in: | Nature medicine 2012-06, Vol.18 (6), p.911-917 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 917 |
---|---|
container_issue | 6 |
container_start_page | 911 |
container_title | Nature medicine |
container_volume | 18 |
creator | Shichita, Takashi Hasegawa, Eiichi Kimura, Akihiro Morita, Rimpei Sakaguchi, Ryota Takada, Ichiro Sekiya, Takashi Ooboshi, Hiroaki Kitazono, Takanari Yanagawa, Toru Ishii, Tetsuro Takahashi, Hideo Mori, Shuji Nishibori, Masahiro Kuroda, Kazumichi Akira, Shizuo Miyake, Kensuke Yoshimura, Akihiko |
description | Brain cells that die after stroke release intracellular proteins into their environment. Akihiko Yoshimura and his colleagues demonstrate that peroxiredoxin proteins released from dying cells induce inflammatory cytokine expression and drive brain damage after stroke.
Post-ischemic inflammation is an essential step in the progression of brain ischemia-reperfusion injury. However, the mechanism that activates infiltrating macrophages in the ischemic brain remains to be clarified. Here we demonstrate that peroxiredoxin (Prx) family proteins released extracellularly from necrotic brain cells induce expression of inflammatory cytokines including interleukin-23 in macrophages through activation of Toll-like receptor 2 (TLR2) and TLR4, thereby promoting neural cell death, even though intracellular Prxs have been shown to be neuroprotective. The extracellular release of Prxs in the ischemic core occurred 12 h after stroke onset, and neutralization of extracellular Prxs with antibodies suppressed inflammatory cytokine expression and infarct volume growth. In contrast, high mobility group box 1 (HMGB1), a well-known damage-associated molecular pattern molecule, was released before Prx and had a limited role in post-ischemic macrophage activation. We thus propose that extracellular Prxs are previously unknown danger signals in the ischemic brain and that its blocking agents are potent neuroprotective tools. |
doi_str_mv | 10.1038/nm.2749 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1399903099</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A293686258</galeid><sourcerecordid>A293686258</sourcerecordid><originalsourceid>FETCH-LOGICAL-c645t-5a4041c0338eee8d9d7fa85b2cab322c928df4f6fde64ba1b8bcdbc2669f5bfa3</originalsourceid><addsrcrecordid>eNqN0luL1DAYBuAgiruu4j-QguDhomMObZpcLouHhYUVTwhelDT9MpO1TcYkhZ1_b8quOpUBpZC2yZOP5E0QekzwimAmXrlxRZtK3kHHpK54SRr89W7-xo0ohaz5EXoQ4xXGmOFa3kdHlHKCqcDH6Nt7CP7aBuhz6wqjRjvsim3wCayLhQpQfIddYZ1NViUfYuFNsfUxlTbqDYxW5zEzqHFUyXqXf4q0gaILyrqH6J5RQ4RHt-8T9PnN609n78qLy7fnZ6cXpeZVncpaVbgiGjMmAED0sm-MEnVHteoYpVpS0ZvKcNMDrzpFOtHpvtOUc2nqzih2gl7c1M3L_jFBTO2YFwfDoBz4KbaESSnz1qX8N8WMkDpDmunTv-iVn4LLG5kVxoI1eE-t1QBtjsKnoPRctD2lknHBaS2yKg-oNTgIavAOjM3dC7864PPTz4kfnPByMSGbBNdpraYY2_OPH_7fXn5Z2md7dgNqSJvoh2k-67iEz2-gDj7GAKbdBjuqsMthzXmJ1o3tfEWzfHKb69SN0P92v-7knzOKecitIewHv6z1E2KK6t4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1030083702</pqid></control><display><type>article</type><title>Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Nature Journals Online</source><creator>Shichita, Takashi ; Hasegawa, Eiichi ; Kimura, Akihiro ; Morita, Rimpei ; Sakaguchi, Ryota ; Takada, Ichiro ; Sekiya, Takashi ; Ooboshi, Hiroaki ; Kitazono, Takanari ; Yanagawa, Toru ; Ishii, Tetsuro ; Takahashi, Hideo ; Mori, Shuji ; Nishibori, Masahiro ; Kuroda, Kazumichi ; Akira, Shizuo ; Miyake, Kensuke ; Yoshimura, Akihiko</creator><creatorcontrib>Shichita, Takashi ; Hasegawa, Eiichi ; Kimura, Akihiro ; Morita, Rimpei ; Sakaguchi, Ryota ; Takada, Ichiro ; Sekiya, Takashi ; Ooboshi, Hiroaki ; Kitazono, Takanari ; Yanagawa, Toru ; Ishii, Tetsuro ; Takahashi, Hideo ; Mori, Shuji ; Nishibori, Masahiro ; Kuroda, Kazumichi ; Akira, Shizuo ; Miyake, Kensuke ; Yoshimura, Akihiko</creatorcontrib><description>Brain cells that die after stroke release intracellular proteins into their environment. Akihiko Yoshimura and his colleagues demonstrate that peroxiredoxin proteins released from dying cells induce inflammatory cytokine expression and drive brain damage after stroke.
Post-ischemic inflammation is an essential step in the progression of brain ischemia-reperfusion injury. However, the mechanism that activates infiltrating macrophages in the ischemic brain remains to be clarified. Here we demonstrate that peroxiredoxin (Prx) family proteins released extracellularly from necrotic brain cells induce expression of inflammatory cytokines including interleukin-23 in macrophages through activation of Toll-like receptor 2 (TLR2) and TLR4, thereby promoting neural cell death, even though intracellular Prxs have been shown to be neuroprotective. The extracellular release of Prxs in the ischemic core occurred 12 h after stroke onset, and neutralization of extracellular Prxs with antibodies suppressed inflammatory cytokine expression and infarct volume growth. In contrast, high mobility group box 1 (HMGB1), a well-known damage-associated molecular pattern molecule, was released before Prx and had a limited role in post-ischemic macrophage activation. We thus propose that extracellular Prxs are previously unknown danger signals in the ischemic brain and that its blocking agents are potent neuroprotective tools.</description><identifier>ISSN: 1078-8956</identifier><identifier>EISSN: 1546-170X</identifier><identifier>DOI: 10.1038/nm.2749</identifier><identifier>PMID: 22610280</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>631/250/256 ; 692/699/375/1345 ; 692/699/375/380/534 ; Analysis ; Animals ; Antioxidants ; Apoptosis ; Biomedical and Life Sciences ; Biomedicine ; Brain ; Brain - immunology ; Brain damage ; Brain Ischemia - complications ; Cancer Research ; Cytokines ; Encephalitis - etiology ; HMGB1 Protein - physiology ; Infectious Diseases ; Inflammation ; Interleukin-23 - genetics ; Ischemia ; Male ; Metabolic Diseases ; Mice ; Mice, Inbred C57BL ; Molecular Medicine ; Neurosciences ; Neutralization ; Peroxiredoxins - analysis ; Peroxiredoxins - genetics ; Peroxiredoxins - physiology ; Physiological aspects ; Proteins ; Rabbits ; RNA, Messenger - analysis ; Toll-Like Receptor 2 - physiology ; Toll-Like Receptor 4 - physiology</subject><ispartof>Nature medicine, 2012-06, Vol.18 (6), p.911-917</ispartof><rights>Springer Nature America, Inc. 2012</rights><rights>COPYRIGHT 2012 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Jun 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c645t-5a4041c0338eee8d9d7fa85b2cab322c928df4f6fde64ba1b8bcdbc2669f5bfa3</citedby><cites>FETCH-LOGICAL-c645t-5a4041c0338eee8d9d7fa85b2cab322c928df4f6fde64ba1b8bcdbc2669f5bfa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/nm.2749$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/nm.2749$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22610280$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shichita, Takashi</creatorcontrib><creatorcontrib>Hasegawa, Eiichi</creatorcontrib><creatorcontrib>Kimura, Akihiro</creatorcontrib><creatorcontrib>Morita, Rimpei</creatorcontrib><creatorcontrib>Sakaguchi, Ryota</creatorcontrib><creatorcontrib>Takada, Ichiro</creatorcontrib><creatorcontrib>Sekiya, Takashi</creatorcontrib><creatorcontrib>Ooboshi, Hiroaki</creatorcontrib><creatorcontrib>Kitazono, Takanari</creatorcontrib><creatorcontrib>Yanagawa, Toru</creatorcontrib><creatorcontrib>Ishii, Tetsuro</creatorcontrib><creatorcontrib>Takahashi, Hideo</creatorcontrib><creatorcontrib>Mori, Shuji</creatorcontrib><creatorcontrib>Nishibori, Masahiro</creatorcontrib><creatorcontrib>Kuroda, Kazumichi</creatorcontrib><creatorcontrib>Akira, Shizuo</creatorcontrib><creatorcontrib>Miyake, Kensuke</creatorcontrib><creatorcontrib>Yoshimura, Akihiko</creatorcontrib><title>Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain</title><title>Nature medicine</title><addtitle>Nat Med</addtitle><addtitle>Nat Med</addtitle><description>Brain cells that die after stroke release intracellular proteins into their environment. Akihiko Yoshimura and his colleagues demonstrate that peroxiredoxin proteins released from dying cells induce inflammatory cytokine expression and drive brain damage after stroke.
Post-ischemic inflammation is an essential step in the progression of brain ischemia-reperfusion injury. However, the mechanism that activates infiltrating macrophages in the ischemic brain remains to be clarified. Here we demonstrate that peroxiredoxin (Prx) family proteins released extracellularly from necrotic brain cells induce expression of inflammatory cytokines including interleukin-23 in macrophages through activation of Toll-like receptor 2 (TLR2) and TLR4, thereby promoting neural cell death, even though intracellular Prxs have been shown to be neuroprotective. The extracellular release of Prxs in the ischemic core occurred 12 h after stroke onset, and neutralization of extracellular Prxs with antibodies suppressed inflammatory cytokine expression and infarct volume growth. In contrast, high mobility group box 1 (HMGB1), a well-known damage-associated molecular pattern molecule, was released before Prx and had a limited role in post-ischemic macrophage activation. We thus propose that extracellular Prxs are previously unknown danger signals in the ischemic brain and that its blocking agents are potent neuroprotective tools.</description><subject>631/250/256</subject><subject>692/699/375/1345</subject><subject>692/699/375/380/534</subject><subject>Analysis</subject><subject>Animals</subject><subject>Antioxidants</subject><subject>Apoptosis</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain</subject><subject>Brain - immunology</subject><subject>Brain damage</subject><subject>Brain Ischemia - complications</subject><subject>Cancer Research</subject><subject>Cytokines</subject><subject>Encephalitis - etiology</subject><subject>HMGB1 Protein - physiology</subject><subject>Infectious Diseases</subject><subject>Inflammation</subject><subject>Interleukin-23 - genetics</subject><subject>Ischemia</subject><subject>Male</subject><subject>Metabolic Diseases</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Molecular Medicine</subject><subject>Neurosciences</subject><subject>Neutralization</subject><subject>Peroxiredoxins - analysis</subject><subject>Peroxiredoxins - genetics</subject><subject>Peroxiredoxins - physiology</subject><subject>Physiological aspects</subject><subject>Proteins</subject><subject>Rabbits</subject><subject>RNA, Messenger - analysis</subject><subject>Toll-Like Receptor 2 - physiology</subject><subject>Toll-Like Receptor 4 - physiology</subject><issn>1078-8956</issn><issn>1546-170X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqN0luL1DAYBuAgiruu4j-QguDhomMObZpcLouHhYUVTwhelDT9MpO1TcYkhZ1_b8quOpUBpZC2yZOP5E0QekzwimAmXrlxRZtK3kHHpK54SRr89W7-xo0ohaz5EXoQ4xXGmOFa3kdHlHKCqcDH6Nt7CP7aBuhz6wqjRjvsim3wCayLhQpQfIddYZ1NViUfYuFNsfUxlTbqDYxW5zEzqHFUyXqXf4q0gaILyrqH6J5RQ4RHt-8T9PnN609n78qLy7fnZ6cXpeZVncpaVbgiGjMmAED0sm-MEnVHteoYpVpS0ZvKcNMDrzpFOtHpvtOUc2nqzih2gl7c1M3L_jFBTO2YFwfDoBz4KbaESSnz1qX8N8WMkDpDmunTv-iVn4LLG5kVxoI1eE-t1QBtjsKnoPRctD2lknHBaS2yKg-oNTgIavAOjM3dC7864PPTz4kfnPByMSGbBNdpraYY2_OPH_7fXn5Z2md7dgNqSJvoh2k-67iEz2-gDj7GAKbdBjuqsMthzXmJ1o3tfEWzfHKb69SN0P92v-7knzOKecitIewHv6z1E2KK6t4</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Shichita, Takashi</creator><creator>Hasegawa, Eiichi</creator><creator>Kimura, Akihiro</creator><creator>Morita, Rimpei</creator><creator>Sakaguchi, Ryota</creator><creator>Takada, Ichiro</creator><creator>Sekiya, Takashi</creator><creator>Ooboshi, Hiroaki</creator><creator>Kitazono, Takanari</creator><creator>Yanagawa, Toru</creator><creator>Ishii, Tetsuro</creator><creator>Takahashi, Hideo</creator><creator>Mori, Shuji</creator><creator>Nishibori, Masahiro</creator><creator>Kuroda, Kazumichi</creator><creator>Akira, Shizuo</creator><creator>Miyake, Kensuke</creator><creator>Yoshimura, Akihiko</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20120601</creationdate><title>Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain</title><author>Shichita, Takashi ; Hasegawa, Eiichi ; Kimura, Akihiro ; Morita, Rimpei ; Sakaguchi, Ryota ; Takada, Ichiro ; Sekiya, Takashi ; Ooboshi, Hiroaki ; Kitazono, Takanari ; Yanagawa, Toru ; Ishii, Tetsuro ; Takahashi, Hideo ; Mori, Shuji ; Nishibori, Masahiro ; Kuroda, Kazumichi ; Akira, Shizuo ; Miyake, Kensuke ; Yoshimura, Akihiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c645t-5a4041c0338eee8d9d7fa85b2cab322c928df4f6fde64ba1b8bcdbc2669f5bfa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>631/250/256</topic><topic>692/699/375/1345</topic><topic>692/699/375/380/534</topic><topic>Analysis</topic><topic>Animals</topic><topic>Antioxidants</topic><topic>Apoptosis</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain</topic><topic>Brain - immunology</topic><topic>Brain damage</topic><topic>Brain Ischemia - complications</topic><topic>Cancer Research</topic><topic>Cytokines</topic><topic>Encephalitis - etiology</topic><topic>HMGB1 Protein - physiology</topic><topic>Infectious Diseases</topic><topic>Inflammation</topic><topic>Interleukin-23 - genetics</topic><topic>Ischemia</topic><topic>Male</topic><topic>Metabolic Diseases</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Molecular Medicine</topic><topic>Neurosciences</topic><topic>Neutralization</topic><topic>Peroxiredoxins - analysis</topic><topic>Peroxiredoxins - genetics</topic><topic>Peroxiredoxins - physiology</topic><topic>Physiological aspects</topic><topic>Proteins</topic><topic>Rabbits</topic><topic>RNA, Messenger - analysis</topic><topic>Toll-Like Receptor 2 - physiology</topic><topic>Toll-Like Receptor 4 - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shichita, Takashi</creatorcontrib><creatorcontrib>Hasegawa, Eiichi</creatorcontrib><creatorcontrib>Kimura, Akihiro</creatorcontrib><creatorcontrib>Morita, Rimpei</creatorcontrib><creatorcontrib>Sakaguchi, Ryota</creatorcontrib><creatorcontrib>Takada, Ichiro</creatorcontrib><creatorcontrib>Sekiya, Takashi</creatorcontrib><creatorcontrib>Ooboshi, Hiroaki</creatorcontrib><creatorcontrib>Kitazono, Takanari</creatorcontrib><creatorcontrib>Yanagawa, Toru</creatorcontrib><creatorcontrib>Ishii, Tetsuro</creatorcontrib><creatorcontrib>Takahashi, Hideo</creatorcontrib><creatorcontrib>Mori, Shuji</creatorcontrib><creatorcontrib>Nishibori, Masahiro</creatorcontrib><creatorcontrib>Kuroda, Kazumichi</creatorcontrib><creatorcontrib>Akira, Shizuo</creatorcontrib><creatorcontrib>Miyake, Kensuke</creatorcontrib><creatorcontrib>Yoshimura, Akihiko</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Nature medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shichita, Takashi</au><au>Hasegawa, Eiichi</au><au>Kimura, Akihiro</au><au>Morita, Rimpei</au><au>Sakaguchi, Ryota</au><au>Takada, Ichiro</au><au>Sekiya, Takashi</au><au>Ooboshi, Hiroaki</au><au>Kitazono, Takanari</au><au>Yanagawa, Toru</au><au>Ishii, Tetsuro</au><au>Takahashi, Hideo</au><au>Mori, Shuji</au><au>Nishibori, Masahiro</au><au>Kuroda, Kazumichi</au><au>Akira, Shizuo</au><au>Miyake, Kensuke</au><au>Yoshimura, Akihiko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain</atitle><jtitle>Nature medicine</jtitle><stitle>Nat Med</stitle><addtitle>Nat Med</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>18</volume><issue>6</issue><spage>911</spage><epage>917</epage><pages>911-917</pages><issn>1078-8956</issn><eissn>1546-170X</eissn><abstract>Brain cells that die after stroke release intracellular proteins into their environment. Akihiko Yoshimura and his colleagues demonstrate that peroxiredoxin proteins released from dying cells induce inflammatory cytokine expression and drive brain damage after stroke.
Post-ischemic inflammation is an essential step in the progression of brain ischemia-reperfusion injury. However, the mechanism that activates infiltrating macrophages in the ischemic brain remains to be clarified. Here we demonstrate that peroxiredoxin (Prx) family proteins released extracellularly from necrotic brain cells induce expression of inflammatory cytokines including interleukin-23 in macrophages through activation of Toll-like receptor 2 (TLR2) and TLR4, thereby promoting neural cell death, even though intracellular Prxs have been shown to be neuroprotective. The extracellular release of Prxs in the ischemic core occurred 12 h after stroke onset, and neutralization of extracellular Prxs with antibodies suppressed inflammatory cytokine expression and infarct volume growth. In contrast, high mobility group box 1 (HMGB1), a well-known damage-associated molecular pattern molecule, was released before Prx and had a limited role in post-ischemic macrophage activation. We thus propose that extracellular Prxs are previously unknown danger signals in the ischemic brain and that its blocking agents are potent neuroprotective tools.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>22610280</pmid><doi>10.1038/nm.2749</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1078-8956 |
ispartof | Nature medicine, 2012-06, Vol.18 (6), p.911-917 |
issn | 1078-8956 1546-170X |
language | eng |
recordid | cdi_proquest_miscellaneous_1399903099 |
source | MEDLINE; Springer Nature - Complete Springer Journals; Nature Journals Online |
subjects | 631/250/256 692/699/375/1345 692/699/375/380/534 Analysis Animals Antioxidants Apoptosis Biomedical and Life Sciences Biomedicine Brain Brain - immunology Brain damage Brain Ischemia - complications Cancer Research Cytokines Encephalitis - etiology HMGB1 Protein - physiology Infectious Diseases Inflammation Interleukin-23 - genetics Ischemia Male Metabolic Diseases Mice Mice, Inbred C57BL Molecular Medicine Neurosciences Neutralization Peroxiredoxins - analysis Peroxiredoxins - genetics Peroxiredoxins - physiology Physiological aspects Proteins Rabbits RNA, Messenger - analysis Toll-Like Receptor 2 - physiology Toll-Like Receptor 4 - physiology |
title | Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T06%3A43%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peroxiredoxin%20family%20proteins%20are%20key%20initiators%20of%20post-ischemic%20inflammation%20in%20the%20brain&rft.jtitle=Nature%20medicine&rft.au=Shichita,%20Takashi&rft.date=2012-06-01&rft.volume=18&rft.issue=6&rft.spage=911&rft.epage=917&rft.pages=911-917&rft.issn=1078-8956&rft.eissn=1546-170X&rft_id=info:doi/10.1038/nm.2749&rft_dat=%3Cgale_proqu%3EA293686258%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1030083702&rft_id=info:pmid/22610280&rft_galeid=A293686258&rfr_iscdi=true |